Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2009

Open Access 01-12-2009 | Research

Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R

Authors: Anne Schmidt, Kerstin Wenninger, Nadja Niemann, Ulrich Wahn, Doris Staab

Published in: Health and Quality of Life Outcomes | Issue 1/2009

Login to get access

Abstract

Background

This study evaluates the psychometric properties of the Child and Parent versions of the German CFQ-R (Cystic Fibrosis Questionnaire Revised), a disease-specific measure of Health-Related Quality of Life (HRQoL) in children with cystic fibrosis (CF). Self-Rating is combined with proxy-rating by parents in the use of the questionnaire.

Methods

136 children with CF (6 - 13 years) and their parents were recruited to evaluate internal consistency (Cronbach's α) and validity, 20 children and parents to examine reproducibility (ICC).

Results

Cronbach's α is high in all but two dimensions of the Child version (α = 0.23-0.77) and for all dimensions of the Parent version (α = 0.69-0.89). For both questionnaires, reproducibility is moderate to high (ICC = 0.50-0.94). Factor analysis shows loadings of >0.4 in the majority of items. Higher HRQoL is reported by children with mild disease compared to those with moderate/severe disease and by boys compared to girls. Convergence between self-rating and proxy-rating depends on the dimension.

Conclusion

The German CFQ-R, Child and Parent versions, are reliable and valid measures of HRQoL. They should be administered in combination as both, child and parent, provide important information. The measure offers a new patient-reported outcome for clinical purposes as well as for national and international studies in schoolchildren.
Appendix
Available only for authorised users
Literature
1.
go back to reference FitzSimmons SC: The changing epidemiology of cystic fibrosis. J Pediatr 1993,122(1):1–9. 10.1016/S0022-3476(05)83478-XCrossRef FitzSimmons SC: The changing epidemiology of cystic fibrosis. J Pediatr 1993,122(1):1–9. 10.1016/S0022-3476(05)83478-XCrossRef
2.
go back to reference Stern M, Wiedemann B, Wenzlaff P: From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 2008,31(1):29–35. 10.1183/09031936.00056507CrossRef Stern M, Wiedemann B, Wenzlaff P: From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 2008,31(1):29–35. 10.1183/09031936.00056507CrossRef
3.
go back to reference Abbott JHA: Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes 2005.,3(19): Abbott JHA: Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes 2005.,3(19):
4.
go back to reference Staab D, Wenninger K, Gebert N, Rupprath K, Bisson S, Trettin M, Paul KD, Keller KM, Wahn U: Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998,53(9):727–31. 10.1136/thx.53.9.727CrossRef Staab D, Wenninger K, Gebert N, Rupprath K, Bisson S, Trettin M, Paul KD, Keller KM, Wahn U: Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998,53(9):727–31. 10.1136/thx.53.9.727CrossRef
5.
go back to reference Goss CH, Quittner AL: Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007,4(4):378–86. 10.1513/pats.200703-039BRCrossRef Goss CH, Quittner AL: Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007,4(4):378–86. 10.1513/pats.200703-039BRCrossRef
6.
go back to reference Cella DF: Quality of life: the concept. J Palliat Care 1992,8(3):8–13. Cella DF: Quality of life: the concept. J Palliat Care 1992,8(3):8–13.
7.
go back to reference Quittner AL: Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med 1998,4(6):326–31. 10.1097/00063198-199811000-00003CrossRef Quittner AL: Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med 1998,4(6):326–31. 10.1097/00063198-199811000-00003CrossRef
8.
go back to reference Wenninger K, Aussage P, Wahn U, Staab D, G.C.F.Q.s. group: The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res 2003,12(1):77–85. 10.1023/A:1022011704399CrossRef Wenninger K, Aussage P, Wahn U, Staab D, G.C.F.Q.s. group: The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res 2003,12(1):77–85. 10.1023/A:1022011704399CrossRef
9.
go back to reference Congleton J, Hodson ME, Duncan-Skingle F: Quality of life in adults with cystic fibrosis. Thorax 1996,51(9):936–40. 10.1136/thx.51.9.936CrossRef Congleton J, Hodson ME, Duncan-Skingle F: Quality of life in adults with cystic fibrosis. Thorax 1996,51(9):936–40. 10.1136/thx.51.9.936CrossRef
10.
go back to reference Congleton J, Hodson ME, Duncan-Skingle F: Do Nottingham Health Profile scores change over time in cystic fibrosis? Respir Med 1998,92(2):268–72. 10.1016/S0954-6111(98)90107-XCrossRef Congleton J, Hodson ME, Duncan-Skingle F: Do Nottingham Health Profile scores change over time in cystic fibrosis? Respir Med 1998,92(2):268–72. 10.1016/S0954-6111(98)90107-XCrossRef
11.
go back to reference Henry B, Aussage P, Grosskopf C, Goehrs JM: Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 2003,12(1):63–76. 10.1023/A:1022037320039CrossRef Henry B, Aussage P, Grosskopf C, Goehrs JM: Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Qual Life Res 2003,12(1):63–76. 10.1023/A:1022037320039CrossRef
12.
go back to reference Gee L, Abbott J, Conway SP, Etherington C, Webb AK: Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000,55(11):946–54. 10.1136/thorax.55.11.946CrossRef Gee L, Abbott J, Conway SP, Etherington C, Webb AK: Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000,55(11):946–54. 10.1136/thorax.55.11.946CrossRef
13.
go back to reference Goldbeck L, Schmitz TG, Henrich G, Herschbach P: Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest 2003,123(1):42–8. 10.1378/chest.123.1.42CrossRef Goldbeck L, Schmitz TG, Henrich G, Herschbach P: Questions on life satisfaction for adolescents and adults with cystic fibrosis: development of a disease-specific questionnaire. Chest 2003,123(1):42–8. 10.1378/chest.123.1.42CrossRef
14.
go back to reference Wenninger K, Staab D, Henry B, Wahn U, udD CFQ-Arbeitsgruppe: Der Fragebogen zur Lebensqualität bei Cystischer Fibrose - Reliabilität und Validität der deutschen Adaptation. Zeitschrift für Medizinische Psychologie 1999, 3: 121–128. Wenninger K, Staab D, Henry B, Wahn U, udD CFQ-Arbeitsgruppe: Der Fragebogen zur Lebensqualität bei Cystischer Fibrose - Reliabilität und Validität der deutschen Adaptation. Zeitschrift für Medizinische Psychologie 1999, 3: 121–128.
15.
go back to reference Quittner AL, Sweeny S, Watrous M, Munzenberger p, Bearss K, Gibson Nitza A, Fisher LA, Henry B: Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 2000,25(6):403–14. 10.1093/jpepsy/25.6.403CrossRef Quittner AL, Sweeny S, Watrous M, Munzenberger p, Bearss K, Gibson Nitza A, Fisher LA, Henry B: Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 2000,25(6):403–14. 10.1093/jpepsy/25.6.403CrossRef
16.
go back to reference Quittner AL, Buu A, Messer MA, Modi AC, Watrous M: Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005,128(4):2347–54. 10.1378/chest.128.4.2347CrossRef Quittner AL, Buu A, Messer MA, Modi AC, Watrous M: Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005,128(4):2347–54. 10.1378/chest.128.4.2347CrossRef
17.
go back to reference Modi AC, Quittner AL: Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003,28(8):535–45. 10.1093/jpepsy/jsg044CrossRef Modi AC, Quittner AL: Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003,28(8):535–45. 10.1093/jpepsy/jsg044CrossRef
18.
go back to reference Klijn PH, van Stel HF, Quittner AL, Net J, Doeleman W, Schans C, Ent CK: Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults. J Cyst Fibros 2004,3(1):29–36. 10.1016/j.jcf.2003.12.006CrossRef Klijn PH, van Stel HF, Quittner AL, Net J, Doeleman W, Schans C, Ent CK: Validation of the Dutch cystic fibrosis questionnaire (CFQ) in adolescents and adults. J Cyst Fibros 2004,3(1):29–36. 10.1016/j.jcf.2003.12.006CrossRef
19.
go back to reference Bregnballe V, Thastum M, Lund LD, Hansen CR, Preissler T, Schiotz PO: Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). J Cyst Fibros 2008,7(6):531–6. 10.1016/j.jcf.2008.06.006CrossRef Bregnballe V, Thastum M, Lund LD, Hansen CR, Preissler T, Schiotz PO: Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+). J Cyst Fibros 2008,7(6):531–6. 10.1016/j.jcf.2008.06.006CrossRef
20.
go back to reference Abbott J, Baumann U, Conway S, Etherington C, Gee L, Schulenburg JM, Webb K: Cross cultural differences in health related quality of life in adolescents with cystic fibrosis. Disabil Rehabil 2001,23(18):837–44. 10.1080/09638280110072913CrossRef Abbott J, Baumann U, Conway S, Etherington C, Gee L, Schulenburg JM, Webb K: Cross cultural differences in health related quality of life in adolescents with cystic fibrosis. Disabil Rehabil 2001,23(18):837–44. 10.1080/09638280110072913CrossRef
21.
go back to reference Tauler E, Vilagut G, Grau G, Gonzalez A, Sanchez E, Figueras G, Vall O, Ferrer M, Alonso J: The spanish version of the paediatric asthma quality of life questionnaire (PAQLQ) metric characteristics and equivalence with the original version. Qual Life Res 2001,10(1):81–91. 10.1023/A:1016622519987CrossRef Tauler E, Vilagut G, Grau G, Gonzalez A, Sanchez E, Figueras G, Vall O, Ferrer M, Alonso J: The spanish version of the paediatric asthma quality of life questionnaire (PAQLQ) metric characteristics and equivalence with the original version. Qual Life Res 2001,10(1):81–91. 10.1023/A:1016622519987CrossRef
22.
go back to reference Landgraf JM: Measuring and monitoring quality of life in children and youth: A brief commentary. Sozial- und Präventivmedizin/Social and Preventive Medicine 2001,46(5):281–282. 10.1007/BF01321076CrossRef Landgraf JM: Measuring and monitoring quality of life in children and youth: A brief commentary. Sozial- und Präventivmedizin/Social and Preventive Medicine 2001,46(5):281–282. 10.1007/BF01321076CrossRef
23.
go back to reference Pless IB, Nolan T: Revision, replication and neglect--research on maladjustment in chronic illness. J Child Psychol Psychiatry 1991,32(2):347–65. 10.1111/j.1469-7610.1991.tb00312.xCrossRef Pless IB, Nolan T: Revision, replication and neglect--research on maladjustment in chronic illness. J Child Psychol Psychiatry 1991,32(2):347–65. 10.1111/j.1469-7610.1991.tb00312.xCrossRef
24.
go back to reference Bregnballe V, Thastum M, Schiotz PO: Psychosocial problems in children with cystic fibrosis. Acta Paediatr 2007,96(1):58–61. 10.1111/j.1651-2227.2006.00014.xCrossRef Bregnballe V, Thastum M, Schiotz PO: Psychosocial problems in children with cystic fibrosis. Acta Paediatr 2007,96(1):58–61. 10.1111/j.1651-2227.2006.00014.xCrossRef
25.
go back to reference Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I: Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008,14(6):582–8. 10.1097/MCP.0b013e3283121cf1CrossRef Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I: Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008,14(6):582–8. 10.1097/MCP.0b013e3283121cf1CrossRef
26.
go back to reference Knudson RJ, Slatin RC, Lebowitz MD, Burrows B: The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976,113(5):587–600. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B: The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976,113(5):587–600.
27.
go back to reference Taussig LM: Advances in cystic fibrosis: bringing the bench to the bedside. Eur J Pediatr 1995,154(9 Suppl 4):S9–10. 10.1007/BF02191495CrossRef Taussig LM: Advances in cystic fibrosis: bringing the bench to the bedside. Eur J Pediatr 1995,154(9 Suppl 4):S9–10. 10.1007/BF02191495CrossRef
28.
go back to reference Cronbach L: Coefficient Alpha and the internal structure of tests. Psychometrika 1951, 16: 297–333. 10.1007/BF02310555CrossRef Cronbach L: Coefficient Alpha and the internal structure of tests. Psychometrika 1951, 16: 297–333. 10.1007/BF02310555CrossRef
29.
go back to reference Ware JE, Brook RH, A Ross Davies, Williams KN, Stewart AL, Rogers WH, et al.: Conceptualization and measurement of health for adults in the Health Insurance Study. Model of health and methodology. Volume I. Doc. no. R-1987/1-HEW. Santa Monica, CA: RAND Corporation; 1980. Ware JE, Brook RH, A Ross Davies, Williams KN, Stewart AL, Rogers WH, et al.: Conceptualization and measurement of health for adults in the Health Insurance Study. Model of health and methodology. Volume I. Doc. no. R-1987/1-HEW. Santa Monica, CA: RAND Corporation; 1980.
30.
go back to reference Deyo RADP, Patrick DL: Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991,12(4 Suppl):142S-158S. 10.1016/S0197-2456(05)80019-4CrossRef Deyo RADP, Patrick DL: Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991,12(4 Suppl):142S-158S. 10.1016/S0197-2456(05)80019-4CrossRef
31.
go back to reference Kline P: An easy guide to factor analysis. London: Routledge; 1994. Kline P: An easy guide to factor analysis. London: Routledge; 1994.
32.
go back to reference Bühner : Einführung in die Test- und Fragebogenkonstruktion (Introduction to Construction of Tests and Questionnaires). Edited by: Studium P. Munich: Pearson Education; 2004. Bühner : Einführung in die Test- und Fragebogenkonstruktion (Introduction to Construction of Tests and Questionnaires). Edited by: Studium P. Munich: Pearson Education; 2004.
33.
go back to reference Juniper EF, Guyatt GH, Streiner DL, King DR: Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997,50(3):233–8. 10.1016/S0895-4356(96)00377-0CrossRef Juniper EF, Guyatt GH, Streiner DL, King DR: Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol 1997,50(3):233–8. 10.1016/S0895-4356(96)00377-0CrossRef
34.
go back to reference Fayers PM, Hand DJ: Factor analysis, causal indicators and quality of life. Qual Life Res 1997,6(2):139–50. 10.1023/A:1026490117121CrossRef Fayers PM, Hand DJ: Factor analysis, causal indicators and quality of life. Qual Life Res 1997,6(2):139–50. 10.1023/A:1026490117121CrossRef
35.
go back to reference Ravens-Sieberer U, Bullinger M: Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998,7(5):399–407. 10.1023/A:1008853819715CrossRef Ravens-Sieberer U, Bullinger M: Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 1998,7(5):399–407. 10.1023/A:1008853819715CrossRef
36.
go back to reference Arrington-Sanders R, Yi MS, Tsevat J, Wilmott RW, Mrus JM, Britto MT: Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes 2006, 4: 5. 10.1186/1477-7525-4-5CrossRef Arrington-Sanders R, Yi MS, Tsevat J, Wilmott RW, Mrus JM, Britto MT: Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes 2006, 4: 5. 10.1186/1477-7525-4-5CrossRef
37.
go back to reference Thomas C, Mitchell P, O'Rourke C, Wainwright C: Quality of life in children and adolescent with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland. J Pediatr 2006,148(4):508–516. 10.1016/j.jpeds.2005.11.040CrossRef Thomas C, Mitchell P, O'Rourke C, Wainwright C: Quality of life in children and adolescent with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland. J Pediatr 2006,148(4):508–516. 10.1016/j.jpeds.2005.11.040CrossRef
38.
go back to reference O'Connor G, Quinton H, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M, Brooks J, NNECF Consortium: Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pumlonol 2002,33(2):99–105. 10.1002/ppul.10042CrossRef O'Connor G, Quinton H, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M, Brooks J, NNECF Consortium: Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pumlonol 2002,33(2):99–105. 10.1002/ppul.10042CrossRef
39.
go back to reference Demko CA, Byard PJ, Davis PB: Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995,48(8):1041–9. 10.1016/0895-4356(94)00230-NCrossRef Demko CA, Byard PJ, Davis PB: Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995,48(8):1041–9. 10.1016/0895-4356(94)00230-NCrossRef
40.
go back to reference Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B: Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997,145(9):794–803.CrossRef Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B: Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997,145(9):794–803.CrossRef
41.
go back to reference Riekert KA, Bartlett SJ, Boyle M, Krishnan JA, Rand CS: The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007,132(1):231–7. 10.1378/chest.06-2474CrossRef Riekert KA, Bartlett SJ, Boyle M, Krishnan JA, Rand CS: The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007,132(1):231–7. 10.1378/chest.06-2474CrossRef
42.
go back to reference Lai H-C, Kosorok MR, Laxova A, Makholm LM, Farrell PM: Delayed Diagnosis of US Females with Cystic Fibrosis. Am J Epidemiol 2002,156(2):165–173. 10.1093/aje/kwf014CrossRef Lai H-C, Kosorok MR, Laxova A, Makholm LM, Farrell PM: Delayed Diagnosis of US Females with Cystic Fibrosis. Am J Epidemiol 2002,156(2):165–173. 10.1093/aje/kwf014CrossRef
43.
go back to reference Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, Cowley E, Hamilton T, Eidelmann D, Stevenson M, Radzioch D: Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002, 107: 297–305. 10.1046/j.1365-2567.2002.01508.xCrossRef Guilbault C, Stotland P, Lachance C, Tam M, Keller A, Thompson-Snipes L, Cowley E, Hamilton T, Eidelmann D, Stevenson M, Radzioch D: Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002, 107: 297–305. 10.1046/j.1365-2567.2002.01508.xCrossRef
44.
go back to reference Landgraf JM: Measuring health-related quality of life in pediatric oncology patients: a brief commentary on the state of the art of measurement and application (discussion). Int J Cancer Suppl 1999, 12: 147–50. 10.1002/(SICI)1097-0215(1999)83:12+<147::AID-IJC26>3.0.CO;2-OCrossRef Landgraf JM: Measuring health-related quality of life in pediatric oncology patients: a brief commentary on the state of the art of measurement and application (discussion). Int J Cancer Suppl 1999, 12: 147–50. 10.1002/(SICI)1097-0215(1999)83:12+<147::AID-IJC26>3.0.CO;2-OCrossRef
45.
go back to reference Havermans T, Vreys M, Proesmans M, De Boeck C: Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child Care Health Dev 2006,32(1):1–7. 10.1111/j.1365-2214.2006.00564.xCrossRef Havermans T, Vreys M, Proesmans M, De Boeck C: Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis. Child Care Health Dev 2006,32(1):1–7. 10.1111/j.1365-2214.2006.00564.xCrossRef
46.
go back to reference Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty C, Marks GB, Belousova EG, Xuan W, Bye PT: A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006,354(3):229–40. 10.1056/NEJMoa043900CrossRef Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty C, Marks GB, Belousova EG, Xuan W, Bye PT: A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006,354(3):229–40. 10.1056/NEJMoa043900CrossRef
47.
go back to reference Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB: Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009,135(6):1610–8. 10.1378/chest.08-1190CrossRef Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB: Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009,135(6):1610–8. 10.1378/chest.08-1190CrossRef
Metadata
Title
Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R
Authors
Anne Schmidt
Kerstin Wenninger
Nadja Niemann
Ulrich Wahn
Doris Staab
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2009
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-7-97

Other articles of this Issue 1/2009

Health and Quality of Life Outcomes 1/2009 Go to the issue